https://orcid.org/0000-0001-5178-1503
Citations (36)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Ruifeng Chen, Hu Li, Wuyang Zhu, Hongbin Cheng, Yu Li, Xiaomei Li, Faliang Li, Xiaoqiang Liu, Shixiong Hu, Baigang Yan, Yishan Zheng, Yongbo Zuo, Guanmu Dong & Xiangming Li. (2023) Expert consensus on the clinical application of ormutivimab injection for use against the rabies virus. Expert Opinion on Drug Safety 0:0, pages 1-8.
Read now
Read now
Anita Hansda, Debarati Biswas, Aishwarya Bhatta, Nishant Chakravorty & Gayatri Mukherjee. (2022) Plasma therapy: a passive resistance against the deadliest. Human Vaccines & Immunotherapeutics 18:2.
Read now
Read now
Ravish S. Haradanhalli, Nitu Kumari, Mysore K. Sudarshan, D. H. Ashwath Narayana, Ramya M. Prashanth & Jithin Surendran. (2021) Defining the volume of rabies immunoglobulins/ rabies monoclonal antibodies requirement for wound infiltration of category III animal exposures – an exploratory study. Human Vaccines & Immunotherapeutics 17:12, pages 5355-5360.
Read now
Read now
Grace S. Hwang, Elsie Rizk, Lan N. Bui, Tomona Iso, Emily I. Sartain, Anh Thu Tran & Joshua T. Swan. (2020) Adherence to guideline recommendations for human rabies immune globulin patient selection, dosing, timing, and anatomical site of administration in rabies postexposure prophylaxis. Human Vaccines & Immunotherapeutics 16:1, pages 51-60.
Read now
Read now
Omesh Kumar Bharti, Daleep Tekta, Ambuj Shandil, Kalpana Sharma & Piyush Kapila. (2019) Failure of postexposure prophylaxis in a girl child attacked by rabid dog severing her facial nerve causing possible direct entry of rabies virus into the facial nerve. Human Vaccines & Immunotherapeutics 15:11, pages 2612-2614.
Read now
Read now
Articles from other publishers (31)
James Harris, Alexandra Uren, James Smith, Emily Titmus & Megan Young. (2023) Evaluating the benefit of serology during potential Australian bat lyssavirus and rabies post-exposure prophylaxis. Australian and New Zealand Journal of Public Health 47:6, pages 100091.
Crossref
Crossref
Xiaoqiang Liu, Yufeng Li, Jingyu Li, Jianmei Zhou, Jiangshu Guo, Yi Pu, Ya Jiang, Yaling Zhou, Zhiwei Jiang, Qun Shu, Cha Wang, Jingke Wang, Yu Zhao, Wei Zhao, Hui Wang, Jingshuang Wei, Hancheng Yu, Jian Gao & Xiaona Li. (2023) Comparing recombinant human rabies monoclonal antibody (ormutivimab) with human rabies immunoglobulin (HRIG) for postexposure prophylaxis: A phase III, randomized, double-blind, non-inferiority trial. International Journal of Infectious Diseases 134, pages 53-62.
Crossref
Crossref
Jessica Coertse, Natalie Viljoen, Jacqueline Weyer & Wanda Markotter. (2023) Comparative Neutralization Activity of Commercial Rabies Immunoglobulin against Diverse Lyssaviruses. Vaccines 11:7, pages 1255.
Crossref
Crossref
Vanessa Slack & Omesh Kumar Bharti. 2023. One Health for Dog-mediated Rabies Elimination in Asia. One Health for Dog-mediated Rabies Elimination in Asia
74
84
.
Abhishek Royal, Denny John, Omesh Bharti, Diksha Dhupar, Diksha, Retna Siwi Padmawati & Adi Utarini. (2023) Cost analysis of implementation of a population level rabies control programme for children in India. Clinical Epidemiology and Global Health 20, pages 101244.
Crossref
Crossref
Tomona Iso, Fangzheng Yuan, Elsie Rizk, Anh Thu Tran, R. Benjamin Saldana, Prasanth R. Boyareddigari, Ngoc-anh A. Nguyen, Daniela Espino & Joshua T. Swan. (2022) Wound characteristics and infiltration with immune globulin for rabies postexposure prophylaxis in the emergency department. The American Journal of Emergency Medicine 62, pages 55-61.
Crossref
Crossref
Aubin Pitiot, Nathalie Heuzé-Vourc’h & Thomas Sécher. (2022) Alternative Routes of Administration for Therapeutic Antibodies—State of the Art. Antibodies 11:3, pages 56.
Crossref
Crossref
Fangzheng Yuan, Tomona Iso, Elsie Rizk, R. Benjamin Saldana, Anh Thu Tran, Ngoc-anh A. Nguyen, Prasanth R. Boyareddigari, Daniela Espino & Joshua T. Swan. (2022) Implementation of Clinical Decision Support on Emergency Department Delivery of Human Rabies Immune Globulin. JAMA Network Open 5:6, pages e2216631.
Crossref
Crossref
Jaida Hopkins, Samantha Sweck & Sean Richards. 2022. Rabies Virus at the Beginning of 21st Century. Rabies Virus at the Beginning of 21st Century.
Michelle Woznichak, Pete Vandeberg, Catherine Russ, Chad Talton, Jyoti Srivastava, Vik Arora, W. Keither Merritt & Marta Jose. (2021) Application of a caprylate/chromatography purification process for production of a high potency rabies immune globulin from pooled human plasma. Journal of Immunological Methods 499, pages 113164.
Crossref
Crossref
Denny John, Abhishek Royal & Omesh Bharti. (2021) Burden of illness of dog-mediated rabies in India: A systematic review. Clinical Epidemiology and Global Health 12, pages 100804.
Crossref
Crossref
Anurag Agarwal, Pawan Kumar, Surendra Bahadur Mathur & Amir Maroof Khan. (2021) Estimating the Volume of Equine Rabies Immunoglobulin (eRIG) Required for Local Infiltration in Soft Tissue Animal Bites in Children Using a Wound Size-Based Approach. Journal of Tropical Pediatrics 67:4.
Crossref
Crossref
P. Brandon Bookstaver, Peter Akpunonu, Huy‐Binh Nguyen, Joshua T. Swan & Gavin T. Howington. (2021) Administration of rabies immunoglobulin: Improving evidence‐based guidance for wound infiltration. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 41:8, pages 644-648.
Crossref
Crossref
K. M. Chaitra, Sandeep Ballal, N. R. Ramesh Masthi, D. H. Ashwath Narayana, H. T. Yashodha, Mansi Kumar, Afroza Asiya, Divya Bharathi G.Sanjay S. C.. (2021) Rabies encephalitis in a preschool child following postexposure prophylaxis. PLOS Neglected Tropical Diseases 15:2, pages e0009045.
Crossref
Crossref
Felix Gerber, Mathilde Tetchi, Vessaly Kallo, Monique Léchenne, Jan Hattendorf, Bassirou Bonfoh & Jakob Zinsstag. (2020) RABIES IMMUNOGLOBULIN: Brief history and recent experiences in Côte d'Ivoire. Acta Tropica 211, pages 105629.
Crossref
Crossref
Imke Schreuder, Cornelis De Pijper, Rob van Kessel, Leo Visser & Hans van den Kerkhof. (2020) Abandon of intramuscular administration of rabies immunoglobulin for post-exposure prophylaxis in the revised guidelines in the Netherlands in 2018: cost and volume savings. Eurosurveillance 25:38.
Crossref
Crossref
Anita WM Suijkerbuijk, Marie-Josee J Mangen, Manon R Haverkate, Floriana S Luppino, Sabine E Bantjes, Leo G Visser, Corien M Swaan, Wilhelmina LM Ruijs & Eelco AB Over. (2020) Rabies vaccination strategies in the Netherlands in 2018: a cost evaluation. Eurosurveillance 25:38.
Crossref
Crossref
A.-L. Robinson & V.-L. Rahajamanana. (2020) Rabia. EMC - Pediatría 55:3, pages 1-6.
Crossref
Crossref
ShyamKishor Kumar, Pratima Gupta & PrasanKumar Panda. (2020) Death from rabies: The reason being poor compliance to vaccination or it's failure. Journal of Family Medicine and Primary Care 9:8, pages 4437.
Crossref
Crossref
Rodney E. Willoughby & Ernest H. Oertli. 2020. Rabies. Rabies
79
103
.
Charles E. Rupprecht, Mary L. Yager & Richard H. Newhouse. 2020. Rabies and Rabies Vaccines. Rabies and Rabies Vaccines
117
139
.
Seonghye Jeon, Julie Cleaton, Martin I. Meltzer, Emily B. Kahn, Emily G. Pieracci, Jesse D. Blanton & Ryan Wallace. (2019) Determining the post-elimination level of vaccination needed to prevent re-establishment of dog rabies. PLOS Neglected Tropical Diseases 13:12, pages e0007869.
Crossref
Crossref
Amrita Pattanaik & Reeta S. Mani. (2019) WHOʼs new rabies recommendations. Current Opinion in Infectious Diseases 32:5, pages 401-406.
Crossref
Crossref
Omesh Kumar Bharti, Baldev Thakur & Ranjna Rao. (2019) Wound-only injection of rabies immunoglobulin (RIG) saves lives and costs less than a dollar per patient by “pooling strategy”. Vaccine 37, pages A128-A131.
Crossref
Crossref
Charles E. Rupprecht, Ivan V. Kuzmin, Gowri Yale, Thirumeni Nagarajan & Francois-Xavier Meslin. (2019) Priorities in applied research to ensure programmatic success in the global elimination of canine rabies. Vaccine 37, pages A77-A84.
Crossref
Crossref
Martine Denis, Ivana Knezevic, Henry Wilde, Thiravat Hemachudha, Deborah Briggs & Lea Knopf. (2019) An overview of the immunogenicity and effectiveness of current human rabies vaccines administered by intradermal route. Vaccine 37, pages A99-A106.
Crossref
Crossref
Katie Hampson, Bernadette Abela-Ridder, Omesh Bharti, Lea Knopf, Monique Léchenne, Rolande Mindekem, Arnaud Tarantola, Jakob Zinsstag & Caroline Trotter. (2019) Modelling to inform prophylaxis regimens to prevent human rabies. Vaccine 37, pages A166-A173.
Crossref
Crossref
Beatriz P. Quiambao, Cristina Ambas, Sherylle Diego, Valérie Bosch Castells, Joanna Korejwo, Céline Petit & Guy Houillon. (2019) Intradermal post-exposure rabies vaccination with purified Vero cell rabies vaccine: Comparison of a one-week, 4-site regimen versus updated Thai Red Cross regimen in a randomized non-inferiority trial in the Philippines. Vaccine 37:16, pages 2268-2277.
Crossref
Crossref
Jeetha D’Silva. (2018) Celebrating the best in South Asian healthcare: who won a BMJ award?. BMJ, pages k5157.
Crossref
Crossref
Gabriella Ugolini & Thiravat Hemachudha. (2018) Rabies. Current Opinion in Infectious Diseases 31:1, pages 93-101.
Crossref
Crossref
Jatuporn Sirikun, Yupin Suputtamongkol, Ploypailin Rattanachinakorn & Athiwat Primsirikunawut. (2018) Immunogenic response in obese patients undergoing rabies post-exposure prophylaxis with combined equine rabies immunoglobulin and rabies vaccination. Vaccine 36:2, pages 285-291.
Crossref
Crossref